Image

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Naxitamab added in new high-risk neuroblastoma treatment trial.

Recruiting
12-21 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is investigating a new treatment plan for children diagnosed with high-risk neuroblastoma, a type of cancer. The study combines a medicine called naxitamab with standard chemotherapy to see if it improves survival rates. The treatment includes five cycles of chemotherapy, with naxitamab added to each cycle. Participants will be monitored for changes in their disease and overall health. This study is open to children aged 12 months to 21 years, with specific conditions about their cancer diagnosis and health. The trial also involves procedures like stem cell collection and possibly tumor surgery. Participants cannot have certain health issues or be using other experimental drugs. They must agree to use effective birth control if they are of childbearing potential.

  • The study involves five cycles of chemotherapy with added naxitamab.
  • Participants will have disease evaluations at different points in the treatment.
  • Eligible participants may receive compensation for their involvement.
Print
Study details
    High-risk Neuroblastoma

NCT05489887

Giselle Sholler

23 August 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.